BAMF Health partners with Adaptive Research for clinical trials in September 2024

BAMF Health and Adaptive Research announced a strategic partnership on September 16, 2024, aimed at enhancing physician participation and patient enrollment in clinical trials across the United States. This collaboration addresses the disparity in clinical trial accessibility, as most trials are concentrated in major cities with large research hospitals, while the majority of patients receive care in community-based practices. The partnership seeks to empower community physicians by providing them with the necessary resources and support to engage in clinical research. Research indicates that while 80% of physicians express interest in becoming clinical trial investigators, only a small fraction are actively involved, primarily due to administrative challenges. BAMF Health and Adaptive Research plan to identify and engage community physicians who are interested in participating in trials but lack operational support. Their initial focus will be on West Michigan, with intentions to expand their efforts beyond the state. The collaboration combines BAMF Health's expertise in molecular imaging and Theranostics with Adaptive Research's administrative support, creating a comprehensive framework for community physicians. This partnership aims to facilitate patient recruitment, manage trial requirements, and provide staffing assistance, thereby streamlining the clinical trial process for local practices. Leaders from both organizations emphasize the importance of this partnership in democratizing clinical trials and improving access to cutting-edge medical research for diverse populations. By bridging the gap between community practices and clinical research, they aim to enhance the overall efficiency and reach of clinical trials in the radiopharmaceutical industry.